User profiles for Rocío Rubio
Rocío Sánchez Rubioprofesora titular UEX Verified email at unex.es Cited by 1423 |
[HTML][HTML] Tuberculosis cutánea: reporte de dos casos y revisión de la literatura
…, F Fich, R Rabagliati, C Pinto, R Rubio… - Revista chilena de …, 2011 - SciELO Chile
CONCHA R, Marcela et al. Tuberculosis cutánea: reporte de dos casos y revisión de la
literatura. Rev. chil. infectol.[online]. 2011, vol. 28, n. 3, pp. 262-268. ISSN 0716-1018 …
literatura. Rev. chil. infectol.[online]. 2011, vol. 28, n. 3, pp. 262-268. ISSN 0716-1018 …
[HTML][HTML] Seven-month kinetics of SARS-CoV-2 antibodies and role of pre-existing antibodies to human coronaviruses
Unraveling the long-term kinetics of antibodies to SARS-CoV-2 and the individual characteristics
influencing it, including the impact of pre-existing antibodies to human coronaviruses …
influencing it, including the impact of pre-existing antibodies to human coronaviruses …
[HTML][HTML] Determinants of early antibody responses to COVID-19 mRNA vaccines in a cohort of exposed and naïve healthcare workers
Background Two doses of mRNA vaccination have shown >94% efficacy at preventing
COVID-19 mostly in naïve adults, but it is not clear if the second dose is needed to maximize …
COVID-19 mostly in naïve adults, but it is not clear if the second dose is needed to maximize …
[HTML][HTML] SARS-CoV-2 infection, vaccination, and antibody response trajectories in adults: a cohort study in Catalonia
Background Heterogeneity of the population in relation to infection, COVID-19 vaccination,
and host characteristics is likely reflected in the underlying SARS-CoV-2 antibody responses. …
and host characteristics is likely reflected in the underlying SARS-CoV-2 antibody responses. …
Ambient air pollution in relation to SARS-CoV-2 infection, antibody response, and COVID-19 disease: a cohort study in Catalonia, Spain (COVICAT study)
Background: Emerging evidence links ambient air pollution with coronavirus 2019 (COVID-19)
disease, an association that is methodologically challenging to investigate. Objectives: …
disease, an association that is methodologically challenging to investigate. Objectives: …
[HTML][HTML] Persistence and baseline determinants of seropositivity and reinfection rates in health care workers up to 12.5 months after COVID-19
…, J Vidal-Alaball, G Ruiz-Olalla, M Vidal, R Rubio… - BMC medicine, 2021 - Springer
We assessed the duration and baseline determinants of antibody responses to SARS-CoV-2
spike antigens and the occurrence of reinfections in a prospective cohort of 173 Spanish …
spike antigens and the occurrence of reinfections in a prospective cohort of 173 Spanish …
[HTML][HTML] Infection induced SARS-CoV-2 seroprevalence and heterogeneity of antibody responses in a general population cohort study in Catalonia Spain
Sparse data exist on the complex natural immunity to SARS-CoV-2 at the population level.
We applied a well-validated multiplex serology test in 5000 participants of a general …
We applied a well-validated multiplex serology test in 5000 participants of a general …
[PDF][PDF] No hay paraísos sino los perdidos. Historia de una red clientelista en Bogotá
R Rubio Serrano - 2006 - repository.unipiloto.edu.co
El enfoque metodológico del estudio resulta de gran interés para el trabajo que viene
realizando la maestría en Gestión urbana, por cuanto al ver la manera como las unidades del …
realizando la maestría en Gestión urbana, por cuanto al ver la manera como las unidades del …
Long-term exposure to air pollution and COVID-19 vaccine antibody response in a general population cohort (COVICAT Study, Catalonia)
…, K Papantoniou, R Rubio… - Environmental …, 2023 - ehp.niehs.nih.gov
Background: Ambient air pollution has been associated with COVID-19 disease severity and
antibody response induced by infection. Objectives: We examined the association between …
antibody response induced by infection. Objectives: We examined the association between …
[HTML][HTML] Sustained seropositivity up to 20.5 months after COVID-19
This study evaluated the persistence of IgM, IgA, and IgG to SARS-CoV-2 spike and
nucleocapsid antigens up to 616 days since the onset of symptoms in a longitudinal cohort of 247 …
nucleocapsid antigens up to 616 days since the onset of symptoms in a longitudinal cohort of 247 …